Form 4: Director Chapin Receives NHI Restricted Stock Grant

National Health Investors director Robert Chapin was granted 1,268 shares of restricted common stock, vesting in March 2027.

Summary

• Robert Chapin, a director of National Health Investors Inc. (NHI), was granted 1,268 shares of common stock.
• The transaction occurred on March 3, 2026.
• The shares were granted as restricted stock with a price of $0.
• The restricted stock vests in full on March 3, 2027, contingent on Mr. Chapin's continued service as a director.
• Following this transaction, Mr. Chapin directly beneficially owns 1,268 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard director compensation practices that align interests with long-term shareholder value and encourage board stability.

Positives

• The grant of restricted stock aligns the director's interests with long-term shareholder value.
• The vesting schedule encourages continued service and stability in the board.

Risks

• The vesting of the restricted stock is subject to the director's continued service, meaning the shares could be forfeited if service ceases before March 3, 2027.

Future Outlook

The restricted stock grant vests on March 3, 2027, contingent on the director's continued service. This implies an expectation of continued board tenure for at least another year.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation in the REIT (Real Estate Investment Trust) sector, including healthcare REITs like NHI. These grants are often used to align the interests of insiders with long-term company performance and shareholder value, encouraging retention and strategic oversight.

Comparison to Industry Standards

• Restricted stock grants are a standard component of director compensation packages across publicly traded companies, including healthcare REITs such as Ventas (VTR) and Welltower (WELL).
• The vesting period of one year for this grant is typical for director equity awards, aiming to incentivize continued board service.

Related Party Transactions

• Grant of 1,268 shares of restricted common stock to Director Robert Chapin.

Stakeholder Impact

• Shareholders: The grant aligns director interests with long-term shareholder value.
• Employees: No direct impact on general employees.

Next Steps

• The restricted stock will vest on March 3, 2027, subject to Robert Chapin's continued service as a director.

Key Dates

Recommendation

This Form 4 reports a routine restricted stock grant to a director, which is a standard compensation practice. It does not provide new information that would significantly alter the investment thesis for National Health Investors Inc. Therefore, a "hold" recommendation is appropriate as it neither presents a strong buy nor sell signal based solely on this filing.

Keywords

National Health Investors, NHI, Robert Chapin, Restricted Stock, Stock Grant, Insider Transaction, Form 4, Director Compensation, Equity Award